Related Experiment Videos
Pharmacologic therapy for type 2 diabetes mellitus
Annals of Internal Medicine
|July 6, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes.
The Journal of clinical endocrinology and metabolism·2021
Revitalization of pioglitazone: the optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor.
Diabetes, obesity & metabolism·2016
The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo.
Diabetic medicine : a journal of the British Diabetic Association·2014
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.
Diabetes, obesity & metabolism·2014
Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport.
Journal of internal medicine·2014
In veterans with chronic pain, a whole health team intervention reduced pain interference more than CBT or usual care at 12 mo.
Annals of internal medicine·2026
In symptomatic HF, sacubitril-valsartan vs. dapagliflozin and torsemide vs. furosemide did not differ for health status at 6 mo.
Annals of internal medicine·2026
Blood pressure-lowering drugs reduce risk for major cardiovascular events regardless of CKD G category.
Annals of internal medicine·2026
In noncardioembolic ischemic stroke or high-risk TIA, asundexian reduced ischemic stroke and did not increase major bleeding.
Annals of internal medicine·2026
Public Policy Approaches to Addressing Adult Obesity: A Position Paper From the American College of Physicians.
Annals of internal medicine·2026
Euonymus alatus in diabetes: a review of phytochemistry, pharmacokinetics, and anti-diabetic mechanisms.
Frontiers in pharmacology·2026
Efficacy of citicoline as an add-on therapy in Parkinson's disease: a randomized, double-blind trial.
Parkinsonism & related disorders·2026
PAI-1 As a Therapeutic Target: A State-of-the-Art Review.
Seminars in thrombosis and hemostasis·2026
Community Advisory Board Members Speak Out: Insights From an Opioid Overdose Study.
Health expectations : an international journal of public participation in health care and health policy·2026